SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 323 filers reported holding SEATTLE GENETICS INC in Q3 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $57,000 | +216.7% | 290 | +81.2% | 0.02% | +212.5% |
| Q4 2019 | $18,000 | +28.6% | 160 | 0.0% | 0.01% | +14.3% |
| Q3 2019 | $14,000 | +7.7% | 160 | -15.8% | 0.01% | 0.0% |
| Q2 2019 | $13,000 | -7.1% | 190 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $14,000 | +7.7% | 190 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $13,000 | -18.8% | 190 | -9.5% | 0.01% | -12.5% |
| Q3 2018 | $16,000 | +14.3% | 210 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $14,000 | +16.7% | 210 | -8.7% | 0.01% | +14.3% |
| Q1 2018 | $12,000 | 0.0% | 230 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $12,000 | -99.9% | 230 | -32.4% | 0.01% | -41.7% |
| Q3 2017 | $18,499,000 | +5.2% | 340 | 0.0% | 0.01% | +9.1% |
| Q2 2017 | $17,592,000 | -16.4% | 340 | 0.0% | 0.01% | -15.4% |
| Q1 2017 | $21,043,000 | +105115.0% | 340 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $20,000 | +42.9% | 340 | 0.0% | 0.01% | +44.4% |
| Q2 2016 | $14,000 | +133.3% | 340 | +112.5% | 0.01% | +125.0% |
| Q1 2016 | $6,000 | – | 160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,876,712 | $1,020,792,000 | 8.49% |
| Lagoda Investment Management, L.P. | 617,204 | $21,818,000 | 5.84% |
| Redmile Group, LLC | 1,052,666 | $37,212,000 | 3.34% |
| Opus Point Partners Management, LLC | 111,050 | $3,926,000 | 3.29% |
| SOUND ENERGY PARTNERS, INC. | 10,000 | $354,000 | 2.33% |
| EMORY UNIVERSITY | 29,535 | $1,044,000 | 1.97% |
| SECTORAL ASSET MANAGEMENT INC | 1,260,275 | $44,551,000 | 1.69% |
| CORRADO ADVISORS, LLC | 104,175 | $3,683,000 | 1.59% |
| WASATCH ADVISORS LP | 3,462,749 | $122,408,000 | 1.27% |
| Baillie Gifford | 15,253,520 | $539,213,000 | 1.02% |